Literature DB >> 13873825

Destruction of enteric bacteria in liquid egg with beta-propiolactone.

C W BRUCH, M G KOESTERER.   

Abstract

Liquid whole egg or egg white, inoculated with Escherichia coli 1485, Salmonella senftenberg ATCC 8400, or Salmonella typhimurium 84-I, was treated with concentrations of beta-propiolactone ranging from 0.05 to 0.3%. Egg white containing 1 x 10(3) to 1 x 10(6) cells of E. coli 1485 per ml was sterilized in 1 hr at 27 C by lactone concentrations of 0.2 and 0.3%. Egg white containing 1 x 10(5) cells of S. senftenberg ATCC 8400 per ml was sterilized in 12 hr at 10 C by 0.1% lactone and in 2 to 3 hr by 0.3% lactone at the same temperature. Liquid whole egg inoculated with 1 x 10(5) cells of either species of Salmonella was sterilized in 4 to 5 hr at 10 C with 0.2% lactone or in 2 to 3 hr by 0.3% lactone at this temperature. A mild heat treatment of either 15 min at 37 C or 1 min at 55 C markedly shortened the exposure times required for sterilization by beta-propiolactone at 10 C. After disinfection was complete, the lactone-treated liquid whole egg was reinoculated with low cell numbers of either species of Salmonella to determine the presence of residual lactone or toxic products. Liquid whole egg treated with 0.2% lactone would support the growth of salmonellae after 13 to 14 hr at 10 C. A heat treatment of 45 min at 37 C or 10 min at 55 C immediately after addition of 0.2% lactone allowed growth of the salmonellae in the lactone-treated liquid whole egg. No evidence of residual toxicity from the lactone treatment was found. The amount of lactone needed to prevent the outgrowth of low cell numbers of either strain of Salmonella in liquid whole egg was quantitated. Liquid whole egg containing 0.06 to 0.07% lactone would not support salmonellae growth from inocula of 1 to 10 cells per ml of egg. Lactone concentrations above 0.08% prevented outgrowth of salmonellae inocula of 10 to 200 cells per ml of liquid whole egg.

Entities:  

Keywords:  ANTISEPTICS/pharmacology; EGGS/microbiology; ESCHERICHIA COLI/pharmacology; LACTONES/pharmacology; SALMONELLA/pharmacology

Mesh:

Substances:

Year:  1962        PMID: 13873825      PMCID: PMC1057823          DOI: 10.1128/am.10.2.123-128.1962

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  10 in total

1.  Procedure for sterilization of arterial homografts with beta-propiolactone.

Authors:  G A LOGRIPPO; P R OVERHULSE; D E SZILAGYI; F W HARTMAN
Journal:  Lab Invest       Date:  1955 May-Jun       Impact factor: 5.662

2.  Use of Salmonellae antagonists in fermenting egg white. II. Microbiological methods for the elimination of Salmonellae from egg white.

Authors:  M N MICKELSON; R S FLIPPIN
Journal:  Appl Microbiol       Date:  1960-11

3.  The safety of beta-propiolactone as a biologic sterilizing agent. Clinical evaluation with human plasma and homotransplants.

Authors:  G A LOGRIPPO
Journal:  Angiology       Date:  1961-02       Impact factor: 3.619

4.  Investigations of the use of beta-propiolactone in virus inactivation.

Authors:  G A LOGRIPPO
Journal:  Ann N Y Acad Sci       Date:  1960-01-13       Impact factor: 5.691

5.  Betapropiolactone vapor as a disinfectant.

Authors:  R K HOFFMAN; B WARSHOWSKY
Journal:  Appl Microbiol       Date:  1958-09

6.  Methods for the detection and estimation of numbers of Salmonella in dried eggs and other food products.

Authors:  A F BYRNE; M M RAYMAN; M D SCHNEIDER
Journal:  Appl Microbiol       Date:  1955-11

7.  The effect of beta-propiolactone on bacterial spores.

Authors:  H R CURRAN; F R EVANS
Journal:  J Infect Dis       Date:  1956 Nov-Dec       Impact factor: 5.226

8.  Duck-embryo rabies vaccine; study of fixed virus vaccine grown in embryonated duck eggs and killed with beta-propiolactone (BPL).

Authors:  C G CULBERTSON; F B PECK; H M POWELL
Journal:  J Am Med Assoc       Date:  1956-12-08

9.  Further studies on incomplete carcinogenesis: triethylene melamine (T.E.M.), 1,2-benzanthracene and beta-propiolactone, as initiators of skin tumour formation in the mouse.

Authors:  F J ROE; M H SALAMAN
Journal:  Br J Cancer       Date:  1955-03       Impact factor: 7.640

10.  The carcinogenicity of beta-propiolactone for mouseskin.

Authors:  O M GLENDENNING; F J ROE
Journal:  Br J Cancer       Date:  1956-06       Impact factor: 7.640

  10 in total
  1 in total

1.  The use of beta-propiolactone for the sterilization of heat-labile materials.

Authors:  W Hazeu; H J Hueck
Journal:  Antonie Van Leeuwenhoek       Date:  1965       Impact factor: 2.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.